基本信息
浏览量:0
职业迁徙
个人简介
Dr. Whitlock’s research interests include the biology and treatment of childhood acute leukemias, the development of new drugs for the treatment of childhood cancers, and the biology and treatment of histiocytic disorders. He was the inaugural Vice-Chair for New Agents and Relapse studies for the Acute Lymphoblastic Leukemia Committee of the Children’s Oncology Group (COG), and is current or past Chair or Vice-Chair of several COG clinical trials. He is the lead investigator for an international phase I trial of nelarabine combination therapy for relapsed T-cell ALL (T2008-002: NECTAR) through the Therapeutic Advances in Childhood Leukemia (TACL) consortium, and served two terms as the first chair of TACL’s Steering & Prioritization Committee. He is a past President of the Histiocyte Society, an international scientific organization which supports research in, and conducts clinical trials for, histiocytic disorders.
研究兴趣
论文共 194 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 1287-1287
CANCER MEDICINEno. 3 (2024): e7033-e7033
Sneha Tandon,Sheila Weitzman, Brooklyn Joyce, Bryan Mcguire,Derek Stephens,James Whitlock,Cynthia Hawkins,Bo Yee Ngan,Oussama Abla
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASESno. 1 (2023): e2023035-e2023035
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
Cielle Stapleton, Ashley Doka,Lucie Pecheux, Pauline Tibout,Kathy Brodeur-Robb,James Whitlock,Daniel Morgenstern,Sarah Cohen-Gogo
PEDIATRIC BLOOD & CANCER (2023)
引用0浏览0引用
0
0
PAEDIATRICS & CHILD HEALTHno. 7 (2023): 399-403
Cancer Researchno. 7_Supplement (2023): 4509-4509
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn